Development of domestic multiplex gene panel test for cancer personalized medicine
Not Applicable
Recruiting
- Conditions
- Solid cancers
- Registration Number
- JPRN-jRCT1062200037
- Lead Sponsor
- Ennishi Daisuke
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
1) Age : 16-year-old or more.
2) Performance Status (ECOG criteria) : 0 or 1
3) Histologically proven solid cancers available for the tissues with enough tumor contents.
4) Solid cancers (including cancer of unknown primary ) with unresectable and relapse disease, that 1) do not have standard treatment, 2) have completed or are expected to complete standard treatment.
5) Written informed consent
Exclusion Criteria
Patients who refuse to participate in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The detection rate of actionable genetic alterations
- Secondary Outcome Measures
Name Time Method The successful rate of sequencing<br>The treatment rate of the actionable drugs<br>The concordance rate of the results between panels